Zacks Research Comments on Avantor’s Q1 Earnings (NYSE:AVTR)

Avantor, Inc. (NYSE:AVTR) – Equities research analysts at Zacks Research cut their Q1 2025 earnings per share estimates for shares of Avantor in a report released on Wednesday, February 5th. Zacks Research analyst D. Dey now anticipates that the company will earn $0.24 per share for the quarter, down from their prior forecast of $0.25. The consensus estimate for Avantor’s current full-year earnings is $0.98 per share. Zacks Research also issued estimates for Avantor’s Q2 2025 earnings at $0.26 EPS, Q3 2025 earnings at $0.27 EPS, Q4 2025 earnings at $0.30 EPS, FY2025 earnings at $1.08 EPS, Q4 2026 earnings at $0.35 EPS and FY2026 earnings at $1.23 EPS.

A number of other brokerages have also issued reports on AVTR. UBS Group reiterated a “neutral” rating and set a $25.00 price target (down previously from $29.00) on shares of Avantor in a research report on Friday, January 17th. Raymond James reduced their price target on Avantor from $29.00 to $26.00 and set an “outperform” rating for the company in a research report on Tuesday, January 21st. Wells Fargo & Company reduced their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Monday, October 28th. Robert W. Baird reduced their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research report on Monday, October 28th. Finally, Barclays upped their price objective on Avantor from $25.00 to $26.00 and gave the company an “overweight” rating in a report on Monday. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $27.46.

Avantor Price Performance

Shares of AVTR opened at $21.80 on Friday. The company has a market cap of $14.83 billion, a P/E ratio of 47.38, a PEG ratio of 3.97 and a beta of 1.28. The stock has a fifty day moving average price of $21.75 and a 200 day moving average price of $23.47. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.54 and a quick ratio of 1.06. Avantor has a 12 month low of $19.59 and a 12 month high of $28.00.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in AVTR. Callan Family Office LLC acquired a new position in Avantor in the 4th quarter worth approximately $1,173,000. Candriam S.C.A. grew its holdings in shares of Avantor by 16.8% during the 4th quarter. Candriam S.C.A. now owns 62,130 shares of the company’s stock valued at $1,309,000 after acquiring an additional 8,932 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of Avantor in the fourth quarter worth $33,091,000. Arizona State Retirement System raised its holdings in shares of Avantor by 1.5% during the fourth quarter. Arizona State Retirement System now owns 197,461 shares of the company’s stock worth $4,161,000 after acquiring an additional 2,852 shares in the last quarter. Finally, Proficio Capital Partners LLC acquired a new stake in Avantor during the fourth quarter valued at $695,000. 95.08% of the stock is owned by hedge funds and other institutional investors.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.